Please login to the form below

Off label use

This page shows the latest Off label use news and features for those working in and with pharma, biotech and healthcare.

EU’s 10-year paediatric meds report - not bad, but can do better

label use of adult medicines in children, says the European Commission. ... These include “off-label use of products designed for adults, un-adapted rewards for innovation, and the lack of use of the Orphan Drugs Regulation for paediatric indications”

Latest news

Are rare disease companies naturally more patient-centric?

The starting point for this development pathway is usually off label use, where doctors have been confronted with a difficult patient with very little hope of a true diagnosis or suitable
Promoting off-label use: where to draw the line?

to ensure the safe, effective and targeted off-label use', putting forward eight steps for decision-makers to follow. ... It seems inappropriate under EU law for public authorities to encourage the widespread off-label use of medicines.
Novartis' AMD drug pegpleranib fails phase III programme

s Eylea (aflibercept) and off-label use of Roche's Avastin (bevacizumab).
Up in smoke

of off-label use of hundreds of molecules that have been supposedly 'studied extensively'. ... The very nature of off-label use suggests that there is a lack of evidence and the care with which clinicians use drugs off-label knowing that they haven't
BMS closer to kidney cancer approval for Opdivo

that a sizeable hunk of the turnover for Merck's drug is coming from off-label use in RCC.

More from news
Approximately 1 fully matching, plus 63 partially matching documents found.

Latest Intelligence

Healthcare systems

Healthcare terms - Healthcare systems.
The gold standard of scientific evidence

More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial. ... A path forward. Real-world evidence is already in use around the world.
Does safety sell medicines?

New legislation in Europe introduced in 2012 has also led companies to expand what they collect from just side effects to reports of occupational exposure, off-label use and medication errors. ... Through the collection and review of adverse event
Pharma deals during February 2013

Merck &Co has also returned to the biosimilar race following its exit from the Enbrel development programme after Amgen settled an off-label use case for Aranesp in December 2012. ... Between them they will use crowd sourcing to generate novel ideas on
Changes to pharmacovigilance legislation in Europe

of the marketing authorisation (off-label use), as well as the misuse and abuse of the medicinal product. ... More generally, the competent authority may lay down 'any other conditions or restrictions with regard to the safe and effective use of the

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

"Legal highs" ruling leaves illegal labs laughing

This could explain the popularity of Bake Off and the reason so many Brits seem addicted to cake. ... There is a huge amount of off-label use of licensed medicines by medically qualified prescribers.
"Legal highs" ruling leaves illegal labs laughing

This could explain the popularity of Bake Off and the reason so many Brits seem addicted to cake. ... There is a huge amount of off-label use of licensed medicines by medically qualified prescribers.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Home based, Chief Medical Writer, Medical Communications: Excellent package

Senior Account Manager: Competitive salary commensurate with experience

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Editorial Director – Medical Education (MedComms): Neg

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Senior Medical Writer, Medical Communications: Excellent package

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Account Manager: £40, 000 - £45, 000 benefits

Business Unit Head, Medical Communications, London: Excellent package

Home based, Principal Medical Writer, Medical Communications: Excellent package

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director - Med Comms: Great salary and bebefits

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home based, Editorial Team Leader, Medical Communications: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Client Services Director – Healthcare Advertising - London: Neg

Subscribe to our email news alerts

PMHub

Add my company

StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....